Auris Medical AG: 3rd Quarter Results 2015

Auris Medical has just released financial information on their company for the 3rd quarter. The update includes a summary on their clinical trial programme. As always, it is well worth a read.

http://ir.aurismedical.com/phoenix.zhtml?c=253572&p=irol-newsArticle&ID=2111740

 

Nice to see updated info on AM102. News regarding it kind of went dormant for a while.

 

AM-102 moving forward. Curious to see what the undisclosed target is.

 

Those who wish to, can rate/share/comment on the Facebook update from Auris Medical via the embedded link below. Due to the developments related to the Autifony QUIET-1 study, as well as the acceptance of only healthy volunteers for the upcoming Otonomy OTO-311 phase-I study, not forgetting the media attack by Kerrisdale Capital on SciFluor, Auris Medical is really the only "player in the game" at the moment. Something to think about.

 

Just as a side note with regards to Auris Medical being as you say the only "player in the game" I don't agree.
I actually bought the article on SF0034 which was published in the Journal of Neuroscience, June 10, 2015, and I read it many times with a scientific perspective. And btw I encourage you to do so as well if you haven't done so.
Kerrisdale Capital has a strong opinion on the value of Scifluor as a future treatment, but they failed to understand the scientific evidence and facts proven "in vivo" with the Scifluor experiment on animal models. Of course by no means I admit these experiments guarantee any success in human trials, but Kerrisdale Capital state their arguments with a little excessive authority in my perspective. They seem to jump into quick conlusions without supporting their arguments with scientific evidence. Please read this article and you will understand my point. I simply emphasize the idea that there is no reason yet to put aside the potential of SF0034.
Food for thought.

 

Indeed I have - and more (click the link):



My guess is that you only log in to TinnitusTalk occasionally and therefore miss the continuity: